Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

The dengue vaccine dilemma

Pharma giant Sanofi has been mired in controversy in the Philippines after allegations that its dengue vaccine Dengvaxia, which had been used in a widespread school vaccination programme, was linked to the deaths of children. Since the vaccine’s ban the Philippines has declared a national dengue epidemic, creating a public health dilemma as infection rates soar.

Close
Close
Close

Go Top